Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients

Coco Dekkers; Hidde Smits; Dora Stölzl; Lotte Spekhorst; Edward Knol; Femke van Wijk; Inken Harder; Thomas Werfel; Jochen Schmitt; Andreas Kleinheinz; Susanne Abraham; Judith Thijs; Stephan Weidinger; Marjolein de Bruin-Weller; Daphne Bakker; Julia Drylewicz

doi:10.1111/cea.14585

Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients

Coco Dekkers, Hidde Smits, Dora Stölzl, Lotte Spekhorst, Edward Knol, Femke van Wijk, Inken Harder, Thomas Werfel, Jochen Schmitt, Andreas Kleinheinz, Susanne Abraham, Judith Thijs, Stephan Weidinger, Marjolein de Bruin-Weller, Daphne Bakker, Julia Drylewicz

Research output: Contribution to journal › Letter › Academic › peer-review

2 Downloads (Pure)

Original language	English
Pages (from-to)	97-99
Number of pages	3
Journal	Clinical and Experimental Allergy
Volume	55
Issue number	1
Early online date	24 Oct 2024
DOIs	https://doi.org/10.1111/cea.14585
Publication status	Published - Jan 2025

Access to Document

10.1111/cea.14585Licence: CC BY-NC-ND

Clin Experimental Allergy - 2024 - Dekkers - Type 2 Immune‐Dominant Endotype Is Not Associated With IncreasedFinal published version, 546 KBLicence: CC BY-NC-ND

Cite this

Dekkers, C., Smits, H., Stölzl, D., Spekhorst, L., Knol, E., van Wijk, F., Harder, I., Werfel, T., Schmitt, J., Kleinheinz, A., Abraham, S., Thijs, J., Weidinger, S., de Bruin-Weller, M., Bakker, D., & Drylewicz, J. (2025). Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients. Clinical and Experimental Allergy, 55(1), 97-99. https://doi.org/10.1111/cea.14585

@article{0a3a5b613dfd4c8c9d62bc332be01c94,

title = "Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients",

author = "Coco Dekkers and Hidde Smits and Dora St{\"o}lzl and Lotte Spekhorst and Edward Knol and {van Wijk}, Femke and Inken Harder and Thomas Werfel and Jochen Schmitt and Andreas Kleinheinz and Susanne Abraham and Judith Thijs and Stephan Weidinger and {de Bruin-Weller}, Marjolein and Daphne Bakker and Julia Drylewicz",

year = "2025",

month = jan,

doi = "10.1111/cea.14585",

language = "English",

volume = "55",

pages = "97--99",

journal = "Clinical and Experimental Allergy",

issn = "0954-7894",

publisher = "Wiley-Blackwell",

number = "1",

}

Dekkers, C, Smits, H, Stölzl, D, Spekhorst, L, Knol, E , van Wijk, F, Harder, I, Werfel, T, Schmitt, J, Kleinheinz, A, Abraham, S, Thijs, J, Weidinger, S, de Bruin-Weller, M, Bakker, D & Drylewicz, J 2025, 'Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients', Clinical and Experimental Allergy, vol. 55, no. 1, pp. 97-99. https://doi.org/10.1111/cea.14585

TY - JOUR

T1 - Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients

AU - Dekkers, Coco

AU - Smits, Hidde

AU - Stölzl, Dora

AU - Spekhorst, Lotte

AU - Knol, Edward

AU - van Wijk, Femke

AU - Harder, Inken

AU - Werfel, Thomas

AU - Schmitt, Jochen

AU - Kleinheinz, Andreas

AU - Abraham, Susanne

AU - Thijs, Judith

AU - Weidinger, Stephan

AU - de Bruin-Weller, Marjolein

AU - Bakker, Daphne

AU - Drylewicz, Julia

PY - 2025/1

Y1 - 2025/1

UR - http://www.scopus.com/inward/record.url?scp=85207624138&partnerID=8YFLogxK

U2 - 10.1111/cea.14585

DO - 10.1111/cea.14585

M3 - Letter

C2 - 39449187

SN - 0954-7894

VL - 55

SP - 97

EP - 99

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

IS - 1

ER -

Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients

Access to Document

Other files and links

Cite this